| Reimagining undergraduate medical education in a post-COVID-19 landscape MZ Guo, J Allen, M Sakumoto, A Pahwa, L Santhosh Journal of general internal medicine 37 (9), 2297-2301, 2022 | 14 | 2022 |
| Targeting cancer stem cells with differentiation agents as an alternative to genotoxic chemotherapy for the treatment of malignant testicular germ cell tumors AR Loehr, TM Pierpont, E Gelsleichter, AMD Galang, IR Fernandez, ... Cancers 13 (9), 2045, 2021 | 8 | 2021 |
| Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis C Pereira, GA Arroyo-Martinez, MZ Guo, MS Downey, ER Kelly, KJ Grive, ... Elife 11, e68677, 2022 | 6 | 2022 |
| Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer MZ Guo, KA Marrone, A Spira, K Freeman, SC Scott touchREVIEWS in Oncology & Haematology 17 (1), 42-47, 2021 | 5 | 2021 |
| Definitive chemoradiation and durvalumab consolidation for locally advanced, unresectable KRAS-mutated non-small cell lung cancer MZ Guo, JC Murray, P Ghanem, KR Voong, RK Hales, D Ettinger, VK Lam, ... Clinical lung cancer 23 (7), 620-629, 2022 | 4 | 2022 |
| Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC Survivors ML Hsu, MZ Guo, S Olson, C Eaton, M Boulanger, M Turner, ME Miller, ... Journal of the National Comprehensive Cancer Network 22 (1D), 2024 | 3 | 2024 |
| Tissue and plasma-based mechanisms of resistance to first-line osimertinib in EGFR-mutant NSCLC: A multi-institutional cohort. Z Piotrowska, LN Chen, E Shum, C Park, M Guo, Y Liu, M Tran, JA Marks, ... Journal of Clinical Oncology 41 (16_suppl), 9108-9108, 2023 | 3 | 2023 |
| Adagrasib: a novel inhibitor for KRASG12C-mutated non-small-cell lung cancer MZ Guo, KA Marrone, A Spira, S Rosner Future Oncology 19 (15), 1037-1051, 2023 | 3 | 2023 |
| Infectious complications in patients with non-small cell lung Cancer treated with Immune Checkpoint inhibitors MZ Guo, A Balaji, JC Murray, JE Reuss, SM Steinke, K Bennett, J Naidoo Clinical lung cancer 24 (7), 613-620, 2023 | 2 | 2023 |
| Targeted treatment of non-small cell lung cancer: Focus on capmatinib with companion diagnostics MZ Guo, KA Marrone, A Spira, DM Waterhouse, SC Scott OncoTargets and therapy, 5321-5331, 2021 | 2 | 2021 |
| Poly (ADP-ribose) polymerase inhibition in small cell lung cancer: a review MZ Guo, KA Marrone, A Spira, SC Scott The Cancer Journal 27 (6), 476-481, 2021 | 2 | 2021 |
| Unmet needs, quality of life, and financial toxicity among survivors of lung cancer ML Hsu, MC Boulanger, S Olson, C Eaton, L Prichett, M Guo, M Miller, ... JAMA Network Open 7 (4), e246872-e246872, 2024 | 1 | 2024 |
| Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes S Pasca, MZ Guo, S Wang, K Stokvis, A Shedeck, A Pallavajjala, ... Blood advances 7 (16), 4660-4670, 2023 | 1 | 2023 |
| Sex-Specific Differences in Congenital Diaphragmatic Hernia Mortality SR Sferra, M Guo, AJG Salazar, AB Penikis, AJ Engwall-Gill, A Ebanks, ... The Journal of Pediatrics 259, 113481, 2023 | 1 | 2023 |
| Racial and Ethnic Disparities in Outcomes Among Newborns with Congenital Diaphragmatic Hernia SR Sferra, PS Salvi, AB Penikis, JH Weller, JK Canner, M Guo, ... JAMA Network Open 6 (4), e2310800-e2310800, 2023 | 1 | 2023 |
| PPD01. 02 Identifying Physical, Social, Emotional, and Medical Needs of Lung Cancer Survivors with Advanced Non-Small Cell Lung Cancer M Miller, M Boulanger, M Guo, M Turner, S Olson, C Eaton, M Hsu, ... Journal of Thoracic Oncology 18 (3), e5-e6, 2023 | 1 | 2023 |
| Cell-free DNA (cfDNA)-based measurable residual disease (MRD) detection as a predictor of relapse post-allogeneic blood or marrow transplant (alloBMT) in patients with myeloid … S Pasca, M Guo, S Wang, K Stokvis, A Shedeck, A Pallavajjala, L Haley, ... Blood 140 (Supplement 1), 3429-3430, 2022 | 1 | 2022 |
| Mobocertinib. EGFR ex20ins-specific tyrosine kinase inhibitor, Treatment for non-small cell lung cancer MZ Guo, KA Marrone, A Spira, SC Scott Drugs of the Future 47 (3), 2022 | 1 | 2022 |
| 237 Infectious complications in patients with non-small cell lung cancer treated with anti-PD (L) 1 immune checkpoint inhibitors M Guo, A Balaji, J Murray, J Reuss, SM Steinke, J Naidoo Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 1 | 2021 |
| Neurodevelopmental Outcomes in Children After Fetoscopic Endoluminal Tracheal Occlusion for Severe Congenital Diaphragmatic Hernia: Results From a Multidisciplinary Clinic SR Sferra, AB Penikis, M Guo, AA Baschat, PJ Mogayzel, VJ Burton, ... Journal of pediatric surgery 59 (7), 1271-1276, 2024 | | 2024 |
